CVS Health (NYSE:CVS) announced yesterday that it plans to offer a discount for Narcan, the nasal spray designed to reverse the effects of opioid overdoses, to customers who do not have insurance. The company said it will cut the cost of Narcan from its list price of $125 to $94.99 – the lowest price available for […]
Adapt Pharma
Surgeon general issues rare advisory urging public to carry overdose reversal drug
For the first time in 13 years, the U.S. surgeon general has issued a public health advisory. The last notice, composed in 2005, centered around the risks of drinking during pregnancy. The one issued by surgeon general Jerome Adams today urges the public to carry naloxone, an opioid overdose reversal drug. Get the full story at […]
Trump touts Adapt Pharma’s plan to distribute free opioid-overdose devices to schools
In a wide-ranging speech yesterday detailing his administration’s plan to tackle the opioid crisis in the U.S., President Trump touted Adapt Pharma‘s move to distribute free doses of its overdose-reversal nasal spray, Narcan, to schools and universities. As part of an initiative launched in collaboration with The Clinton Foundation last year, Adapt previously offered 20,000 free cartons of […]
Adapt Pharma touts usability data for Narcan nasal spray
Adapt Pharma touted data today from 2 human factors studies that evaluated the usability of its Narcan nasal spray by adolescents and people with low literacy. The Dublin-based company’s product is a ready-to-use, needle-free device that delivers a single dose of naloxone in a nasal spray to someone experiencing an opioid overdose and does not require […]
Adapt Pharma seeks regulatory nod for naloxone nasal spray in Europe
Adapt Pharma said today that it filed a European Marketing Application for its naloxone hydrochloride nasal spray for the treatment of opioid overdose. The Dublin-based company’s product is a ready-to-use, needle-free device that delivers a single dose of naloxone in an 0.1 mL nasal spray and does not require assembly prior to use, according to […]
FDA approves 2mg Narcan nasal spray for opioid overdose treatment
Adapt Pharma said today that the FDA approved the 2mg formulation of its Narcan nasal spray for the emergency treatment of opioid overdose. The 2mg dose is intended for opioid-dependent patients that are at risk for severe withdrawal, but are not at a high risk for continued opioid exposure. The approval comes 1 year after […]